• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Fennec Pharmaceuticals Inc. - Common Stock (NQ:FENC)

    11.94 -0.84 (-6.57%)
    Streaming Delayed Price Updated: 3:34 PM EDT, Aug 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 273,698
    Open 12.80
    Bid (Size) 11.92 (200)
    Ask (Size) 11.96 (100)
    Prev. Close 12.78
    Today's Range 11.62 - 13.25
    52wk Range 5.650 - 13.25
    Shares Outstanding 28,062,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Adherex Technologies Q2 Earnings Call Highlights ↗
    Adherex Technologies (NASDAQ:FENC), operating as Fennec Pharmaceuticals, reported second-quarter 2026 net product sales of $17.1 million, up approximately 78% from $9.7 million in the prior-year... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter ↗
    Fennec Pharmaceuticals (NASDAQ:FENC) executives outlined the company’s commercial strategy for PEDMARK, its sodium thiosulfate product used to prevent cisplatin-related hearing loss, during a fireside... 
    Via MarketBeat
    Topics Intellectual Property

    Performance

    YTD
    +55.5%
    +55.5%
    1 Month
    +11.1%
    +11.1%
    3 Month
    +69.8%
    +69.8%
    6 Month
    +53.3%
    +53.3%
    1 Year
    +44.7%
    +44.7%

    More News

    Read More
    News headline image
    Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Fennec Pharmaceuticals Inc.
    Via GlobeNewswire
    Fennec Pharmaceuticals (NASDAQ:FENC) Q1 Beat Overshadowed by Surging Costs ↗
    Via Chartmill
    Fennec Pharmaceuticals (NASDAQ:FENC) Reports Q4 2025 Revenue Growth but Misses Earnings Estimates ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For August 14, 2025 ↗
    Via Benzinga
    News headline image
    Fennec Pharmaceuticals Earnings Preview ↗
    Via Benzinga
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Fennec (FENC) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Adherex Technologies Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
    From Fennec Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
    From Fennec Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
    From Fennec Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year ↗
    Via The Motley Fool
    News headline image
    Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue ↗
    Via The Motley Fool
    News headline image
    Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Fennec Q2 Sales Jump 33 Percent ↗
    Via The Motley Fool
    News headline image
    Fennec (FENC) Q2 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property
    News headline image
    Fennec Pharmaceuticals Inc (NASDAQ:FENC) Reports Mixed Q2 2025 Earnings with Revenue Slight Miss and Wider-Than-Expected Loss ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For May 13, 2025 ↗
    Via Benzinga
    News headline image
    Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? ↗
    Via Benzinga
    Topics Economy Stocks
    News headline image
    Earnings Scheduled For March 10, 2025 ↗
    Via Benzinga
    News headline image
    Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗
    Via InvestorPlace
    News headline image
    3 Dirt-Cheap Stocks Under $10 That Could EXPLODE! ↗
    Via InvestorPlace

    Frequently Asked Questions

    Is Fennec Pharmaceuticals Inc. - Common Stock publicly traded?
    Yes, Fennec Pharmaceuticals Inc. - Common Stock is publicly traded.
    What exchange does Fennec Pharmaceuticals Inc. - Common Stock trade on?
    Fennec Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Fennec Pharmaceuticals Inc. - Common Stock?
    The ticker symbol for Fennec Pharmaceuticals Inc. - Common Stock is FENC on the Nasdaq Stock Market
    What is the current price of Fennec Pharmaceuticals Inc. - Common Stock?
    The current price of Fennec Pharmaceuticals Inc. - Common Stock is 11.94
    When was Fennec Pharmaceuticals Inc. - Common Stock last traded?
    The last trade of Fennec Pharmaceuticals Inc. - Common Stock was at 08/12/26 03:34 PM ET
    What is the market capitalization of Fennec Pharmaceuticals Inc. - Common Stock?
    The market capitalization of Fennec Pharmaceuticals Inc. - Common Stock is 335.06M
    How many shares of Fennec Pharmaceuticals Inc. - Common Stock are outstanding?
    Fennec Pharmaceuticals Inc. - Common Stock has 335M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.